Post-earnings recap
Reported
Wed, Apr 29, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's earnings report indicates a significant miss on EPS, which contributed to a 1.32% decline in stock price. The company did not provide revenue figures or guidance, leaving investors uncertain about future performance. Management's defensive tone suggests they are facing challenges but are focused on long-term strategies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.17 | N/A | -68.32% |
| Revenue | N/A | N/A | N/A |
Management expressed concern over the current financial performance but remains committed to future growth initiatives. They highlighted the importance of innovation in their product line.
Management acknowledged challenges in meeting earnings expectations.
They emphasized ongoing investments in product development.
The team remains focused on long-term growth despite short-term setbacks.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—